Paper Details 
Original Abstract of the Article :
Osteosarcoma is a primary form of malignant bone tumor. It is commonly prevalent among children. Treating osteosarcoma with chemotherapy has had limited clinical outcomes due to side effects and the formation of drug resistance. Presently, a mixture of doxorubicin, cisplatin, ifosfamide, epirubicin ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137068/

データ提供:米国国立医学図書館(NLM)

Methotrexate: A Desert Oasis in Osteosarcoma Treatment

[Osteosarcoma] is a challenging [bone cancer] that primarily affects children. This research explores the [clinical therapeutic effects] of combining [methotrexate] with other [chemotherapeutic agents] to treat [osteosarcoma] in children. The authors propose a comprehensive [systematic review and meta-analysis] of existing research to assess the efficacy and safety of this [combination therapy]. This systematic approach aims to provide a robust evaluation of the [clinical benefits] and [potential side effects] of [methotrexate-based combination therapy] in [osteosarcoma] treatment.

Unveiling the Secrets of Osteosarcoma Treatment

This research aims to shed light on the efficacy and safety of [methotrexate-based combination therapy] in [osteosarcoma] treatment. By meticulously analyzing existing research, the authors hope to provide a comprehensive understanding of the [clinical benefits] and [potential risks] of this therapeutic approach. This systematic review will be a valuable resource for healthcare providers seeking to optimize treatment strategies for [osteosarcoma] in children.

Navigating the Sands of Osteosarcoma Treatment

This research embarks on a journey through the vast desert of [osteosarcoma] research, seeking to uncover the most effective treatments for this challenging disease. The authors' systematic approach to reviewing existing research offers a valuable tool for navigating this complex landscape and identifying the best therapeutic options for children battling this devastating cancer.

Dr. Camel's Conclusion

This research holds promise for improving the treatment of [osteosarcoma] in children by systematically evaluating the effectiveness and safety of [methotrexate-based combination therapy]. It is a valuable step in our quest to conquer this devastating disease.

Date :
  1. Date Completed 2021-05-26
  2. Date Revised 2023-01-03
Further Info :

Pubmed ID

34011024

DOI: Digital Object Identifier

PMC8137068

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.